• レポートコード:MRC2102QY0759 • 出版社/出版日: / 2021年1月 • レポート形態:英文、PDF、142ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医薬品、医療 |
Single User | ¥600,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥900,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の抗菌ペプチド市場について種類別(植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチド)、用途別(医薬品、飼料添加物、その他)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗菌ペプチド市場の概要 ・世界の主要地域別抗菌ペプチド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗菌ペプチド市場規模2015-2026:種類別(植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチド) ・世界の抗菌ペプチド市場規模2015-2026:用途別(医薬品、飼料添加物、その他) ・抗菌ペプチドの米国市場規模2015-2020 ・抗菌ペプチドのヨーロッパ市場規模2015-2020 ・抗菌ペプチドの中国市場規模2015-2020 ・抗菌ペプチドの日本市場規模2015-2020 ・抗菌ペプチドの東南アジア市場規模2015-2020 ・抗菌ペプチドのインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・抗菌ペプチドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗菌ペプチドの市場動向・機会・課題 ・調査の結論 |
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of 6.97%, 9.32%, 2.92% and 25.50% respectively in 2019. By region, North America had the highest share of sales, at 35.18 percent.
Market Analysis and Insights: Global Antimicrobial Peptides Market
The global Antimicrobial Peptides market size is projected to reach US$ 7 million by 2026, from US$ 5 million in 2020, at a CAGR of 5.3% during 2021-2026.
Global Antimicrobial Peptides Scope and Market Size
The global Antimicrobial Peptides market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antimicrobial Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Antimicrobial Peptides market is segmented into
Plant Antimicrobial Peptides
Bacterial Antimicrobial Peptides
Animal Antimicrobial Peptides
Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2019.
Segment by Application, the Antimicrobial Peptides market is segmented into
Pharmaceuticals
Feed Additives
Others
Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 84% of the market in 2019.
The Antimicrobial Peptides market is analysed and market size information is provided by regions (countries). Segment by Application, the Antimicrobial Peptides market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antimicrobial Peptides Market Share Analysis
Antimicrobial Peptides market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antimicrobial Peptides business, the date to enter into the Antimicrobial Peptides market, Antimicrobial Peptides product introduction, recent developments, etc.
The major vendors covered:
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
1 Antimicrobial Peptides Market Overview
1.1 Antimicrobial Peptides Product Scope
1.2 Antimicrobial Peptides Segment by Type
1.2.1 Global Antimicrobial Peptides Sales by Type (2020-2026)
1.2.2 Plant Antimicrobial Peptides
1.2.3 Bacterial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Antimicrobial Peptides Segment by Application
1.3.1 Global Antimicrobial Peptides Sales Comparison by Application (2020-2026)
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Antimicrobial Peptides Market Estimates and Forecasts (2015-2026)
1.4.1 Global Antimicrobial Peptides Sales Growth Rate (2015-2026)
1.4.2 Global Antimicrobial Peptides Revenue and Growth Rate (2015-2026)
1.4.3 Global Antimicrobial Peptides Price Trends (2015-2026)
2 Antimicrobial Peptides Estimate and Forecast by Region
2.1 Global Antimicrobial Peptides Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Antimicrobial Peptides Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Antimicrobial Peptides Sales Market Share by Region (2015-2020)
2.2.2 Global Antimicrobial Peptides Revenue Market Share by Region (2015-2020)
2.3 Global Antimicrobial Peptides Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Antimicrobial Peptides Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Antimicrobial Peptides Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Antimicrobial Peptides Estimates and Projections (2015-2026)
2.4.2 Europe Antimicrobial Peptides Estimates and Projections (2015-2026)
2.4.3 China Antimicrobial Peptides Estimates and Projections (2015-2026)
2.4.4 Japan Antimicrobial Peptides Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Antimicrobial Peptides Estimates and Projections (2015-2026)
2.4.6 India Antimicrobial Peptides Estimates and Projections (2015-2026)
3 Global Antimicrobial Peptides Competition Landscape by Players
3.1 Global Top Antimicrobial Peptides Players by Sales (2015-2020)
3.2 Global Top Antimicrobial Peptides Players by Revenue (2015-2020)
3.3 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antimicrobial Peptides as of 2019)
3.4 Global Antimicrobial Peptides Average Price by Company (2015-2020)
3.5 Manufacturers Antimicrobial Peptides Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Antimicrobial Peptides Players (Opinion Leaders)
4 Global Antimicrobial Peptides Market Size by Type
4.1 Global Antimicrobial Peptides Historic Market Review by Type (2015-2020)
4.1.1 Global Antimicrobial Peptides Sales Market Share by Type (2015-2020)
4.1.2 Global Antimicrobial Peptides Revenue Market Share by Type (2015-2020)
4.1.3 Global Antimicrobial Peptides Price by Type (2015-2020)
4.2 Global Antimicrobial Peptides Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Antimicrobial Peptides Sales Forecast by Type (2021-2026)
4.2.2 Global Antimicrobial Peptides Revenue Forecast by Type (2021-2026)
4.2.3 Global Antimicrobial Peptides Price Forecast by Type (2021-2026)
5 Global Antimicrobial Peptides Market Size by Application
5.1 Global Antimicrobial Peptides Historic Market Review by Application (2015-2020)
5.1.1 Global Antimicrobial Peptides Sales Market Share by Application (2015-2020)
5.1.2 Global Antimicrobial Peptides Revenue Market Share by Application (2015-2020)
5.1.3 Global Antimicrobial Peptides Price by Application (2015-2020)
5.2 Global Antimicrobial Peptides Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Antimicrobial Peptides Sales Forecast by Application (2021-2026)
5.2.2 Global Antimicrobial Peptides Revenue Forecast by Application (2021-2026)
5.2.3 Global Antimicrobial Peptides Price Forecast by Application (2021-2026)
6 United States Antimicrobial Peptides Market Facts & Figures
6.1 United States Antimicrobial Peptides Sales Market Share by Company (2015-2020)
6.2 United States Antimicrobial Peptides Sales Market Share by Type (2015-2020)
6.3 United States Antimicrobial Peptides Sales Market Share by Application (2015-2020)
7 Europe Antimicrobial Peptides Market Facts & Figures
7.1 Europe Antimicrobial Peptides Sales Market Share by Company (2015-2020)
7.2 Europe Antimicrobial Peptides Sales Market Share by Type (2015-2020)
7.3 Europe Antimicrobial Peptides Sales Market Share by Application (2015-2020)
8 China Antimicrobial Peptides Market Facts & Figures
8.1 China Antimicrobial Peptides Sales Market Share by Company (2015-2020)
8.2 China Antimicrobial Peptides Sales Market Share by Type (2015-2020)
8.3 China Antimicrobial Peptides Sales Market Share by Application (2015-2020)
9 Japan Antimicrobial Peptides Market Facts & Figures
9.1 Japan Antimicrobial Peptides Sales Market Share by Company (3015-3030)
9.2 Japan Antimicrobial Peptides Sales Market Share by Type (2015-2020)
9.3 Japan Antimicrobial Peptides Sales Market Share by Application (2015-2020)
10 Southeast Asia Antimicrobial Peptides Market Facts & Figures
10.1 Southeast Asia Antimicrobial Peptides Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Antimicrobial Peptides Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Antimicrobial Peptides Sales Market Share by Application (2015-2020)
11 India Antimicrobial Peptides Market Facts & Figures
11.1 India Antimicrobial Peptides Sales Market Share by Company (2015-2020)
11.2 India Antimicrobial Peptides Sales Market Share by Type (2015-2020)
11.3 India Antimicrobial Peptides Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Antimicrobial Peptides Business
12.1 AnaSpec
12.1.1 AnaSpec Corporation Information
12.1.2 AnaSpec Business Overview
12.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AnaSpec Antimicrobial Peptides Products Offered
12.1.5 AnaSpec Recent Development
12.2 AMP Biotech
12.2.1 AMP Biotech Corporation Information
12.2.2 AMP Biotech Business Overview
12.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AMP Biotech Antimicrobial Peptides Products Offered
12.2.5 AMP Biotech Recent Development
12.3 Phoenix Biotech
12.3.1 Phoenix Biotech Corporation Information
12.3.2 Phoenix Biotech Business Overview
12.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Phoenix Biotech Antimicrobial Peptides Products Offered
12.3.5 Phoenix Biotech Recent Development
12.4 Novabiotics
12.4.1 Novabiotics Corporation Information
12.4.2 Novabiotics Business Overview
12.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novabiotics Antimicrobial Peptides Products Offered
12.4.5 Novabiotics Recent Development
12.5 Chinese Peptide
12.5.1 Chinese Peptide Corporation Information
12.5.2 Chinese Peptide Business Overview
12.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Chinese Peptide Antimicrobial Peptides Products Offered
12.5.5 Chinese Peptide Recent Development
12.6 Ontores
12.6.1 Ontores Corporation Information
12.6.2 Ontores Business Overview
12.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ontores Antimicrobial Peptides Products Offered
12.6.5 Ontores Recent Development
12.7 GenScript
12.7.1 GenScript Corporation Information
12.7.2 GenScript Business Overview
12.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GenScript Antimicrobial Peptides Products Offered
12.7.5 GenScript Recent Development
12.8 Hycult Biotech
12.8.1 Hycult Biotech Corporation Information
12.8.2 Hycult Biotech Business Overview
12.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hycult Biotech Antimicrobial Peptides Products Offered
12.8.5 Hycult Biotech Recent Development
12.9 Sunsmile
12.9.1 Sunsmile Corporation Information
12.9.2 Sunsmile Business Overview
12.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sunsmile Antimicrobial Peptides Products Offered
12.9.5 Sunsmile Recent Development
12.10 Ruixing Biotechnology
12.10.1 Ruixing Biotechnology Corporation Information
12.10.2 Ruixing Biotechnology Business Overview
12.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Ruixing Biotechnology Antimicrobial Peptides Products Offered
12.10.5 Ruixing Biotechnology Recent Development
12.11 Zhongnong Yingtai Biotechnology
12.11.1 Zhongnong Yingtai Biotechnology Corporation Information
12.11.2 Zhongnong Yingtai Biotechnology Business Overview
12.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Products Offered
12.11.5 Zhongnong Yingtai Biotechnology Recent Development
12.12 Glam Technology
12.12.1 Glam Technology Corporation Information
12.12.2 Glam Technology Business Overview
12.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Glam Technology Antimicrobial Peptides Products Offered
12.12.5 Glam Technology Recent Development
13 Antimicrobial Peptides Manufacturing Cost Analysis
13.1 Antimicrobial Peptides Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antimicrobial Peptides
13.4 Antimicrobial Peptides Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antimicrobial Peptides Distributors List
14.3 Antimicrobial Peptides Customers
15 Market Dynamics
15.1 Antimicrobial Peptides Market Trends
15.2 Antimicrobial Peptides Opportunities and Drivers
15.3 Antimicrobial Peptides Market Challenges
15.4 Antimicrobial Peptides Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antimicrobial Peptides Sales (Mg) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Antimicrobial Peptides Sales (Mg) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Antimicrobial Peptides Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Antimicrobial Peptides Sales (Mg) by Region (2015-2020)
Table 5. Global Antimicrobial Peptides Sales Market Share by Region (2015-2020)
Table 6. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Antimicrobial Peptides Revenue Share by Region (2015-2020)
Table 8. Global Antimicrobial Peptides Sales (Mg) Forecast by Region (2021-2026)
Table 9. Global Antimicrobial Peptides Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Antimicrobial Peptides Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Antimicrobial Peptides Revenue Share Forecast by Region (2021-2026)
Table 12. Global Antimicrobial Peptides (Mg) of Key Companies (2015-2020)
Table 13. Global Antimicrobial Peptides Sales Share by Company (2015-2020)
Table 14. Global Antimicrobial Peptides Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Antimicrobial Peptides Revenue Share by Company (2015-2020)
Table 16. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antimicrobial Peptides as of 2019)
Table 17. Global Antimicrobial Peptides Average Price (US$/Mg) of Key Company (2015-2020)
Table 18. Manufacturers Antimicrobial Peptides Manufacturing Sites and Area Served
Table 19. Manufacturers Antimicrobial Peptides Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Antimicrobial Peptides Players
Table 22. Global Antimicrobial Peptides Sales (Mg) by Type (2015-2020)
Table 23. Global Antimicrobial Peptides Sales Share by Type (2015-2020)
Table 24. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Antimicrobial Peptides Price (Mg) by Type (2015-2020)
Table 26. Global Antimicrobial Peptides Sales Share by Type (2021-2026)
Table 27. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Antimicrobial Peptides Revenue Share by Type (2021-2026)
Table 29. Global Antimicrobial Peptides Price (Mg) by Type (2021-2026)
Table 30. Global Antimicrobial Peptides Sales (Mg) by Application (2015-2020)
Table 31. Global Antimicrobial Peptides Sales Share by Application (2015-2020)
Table 32. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Antimicrobial Peptides Price (Mg) by Application (2015-2020)
Table 34. Global Antimicrobial Peptides Sales (Mg) by Application (2021-2026)
Table 35. Global Antimicrobial Peptides Sales Share by Application (2021-2026)
Table 36. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Antimicrobial Peptides Revenue Share by Application (2021-2026)
Table 38. Global Antimicrobial Peptides Price (Mg) by Application (2021-2026)
Table 39. United States Antimicrobial Peptides Sales (Mg) by Company (2015-2020)
Table 40. United States Antimicrobial Peptides Sales Market Share by Company (2015-2020)
Table 41. United States Antimicrobial Peptides Sales (Mg) by Type (2015-2020)
Table 42. United States Antimicrobial Peptides Sales Market Share by Type (2015-2020)
Table 43. United States Antimicrobial Peptides Sales (Mg) by Application (2015-2020)
Table 44. United States Antimicrobial Peptides Sales Market Share by Application (2015-2020)
Table 45. Europe Antimicrobial Peptides Sales (Mg) by Company (2015-2020)
Table 46. Europe Antimicrobial Peptides Sales Market Share by Company (2015-2020)
Table 47. Europe Antimicrobial Peptides Sales (Mg) by Type (2015-2020)
Table 48. Europe Antimicrobial Peptides Sales Market Share by Type (2015-2020)
Table 49. Europe Antimicrobial Peptides Sales (Mg) by Application (2015-2020)
Table 50. Europe Antimicrobial Peptides Sales Market Share by Type (2015-2020)
Table 51. China Antimicrobial Peptides Sales (Mg) by Company (2015-2020)
Table 52. China Antimicrobial Peptides Sales Market Share by Company (2015-2020)
Table 53. China Antimicrobial Peptides Sales (Mg) by Type (2015-2020)
Table 54. China Antimicrobial Peptides Sales Market Share by Type (2015-2020)
Table 55. China Antimicrobial Peptides Sales (Mg) by Application (2015-2020)
Table 56. China Antimicrobial Peptides Sales Market Share by Application (2015-2020)
Table 57. Japan Antimicrobial Peptides Sales (Mg) by Company (2015-2020)
Table 58. Japan Antimicrobial Peptides Sales Market Share by Company (2015-2020)
Table 59. Japan Antimicrobial Peptides Sales (Mg) by Type (2015-2020)
Table 60. Japan Antimicrobial Peptides Sales Market Share by Type (2015-2020)
Table 61. Japan Antimicrobial Peptides Sales (Mg) by Application (2015-2020)
Table 62. Japan Antimicrobial Peptides Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Antimicrobial Peptides Sales (Mg) by Company (2015-2020)
Table 64. Southeast Asia Antimicrobial Peptides Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Antimicrobial Peptides Sales (Mg) by Type (2015-2020)
Table 66. Southeast Asia Antimicrobial Peptides Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Antimicrobial Peptides Sales (Mg) by Type (2015-2020)
Table 68. Southeast Asia Antimicrobial Peptides Sales Market Share by Application (2015-2020)
Table 69. India Antimicrobial Peptides Sales (Mg) by Company (2015-2020)
Table 70. India Antimicrobial Peptides Sales Market Share by Company (2015-2020)
Table 71. India Antimicrobial Peptides Sales (Mg) by Type (2015-2020)
Table 72. India Antimicrobial Peptides Sales Market Share by Type (2015-2020)
Table 73. India Antimicrobial Peptides Sales (Mg) by Application (2015-2020)
Table 74. India Antimicrobial Peptides Sales Market Share by Application (2015-2020)
Table 75. AnaSpec Corporation Information
Table 76. AnaSpec Description and Business Overview
Table 77. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 78. AnaSpec Antimicrobial Peptides Product
Table 79. AnaSpec Recent Development
Table 80. AMP Biotech Corporation Information
Table 81. AMP Biotech Description and Business Overview
Table 82. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 83. AMP Biotech Antimicrobial Peptides Product
Table 84. AMP Biotech Recent Development
Table 85. Phoenix Biotech Corporation Information
Table 86. Phoenix Biotech Description and Business Overview
Table 87. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 88. Phoenix Biotech Antimicrobial Peptides Product
Table 89. Phoenix Biotech Recent Development
Table 90. Novabiotics Corporation Information
Table 91. Novabiotics Description and Business Overview
Table 92. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 93. Novabiotics Antimicrobial Peptides Product
Table 94. Novabiotics Recent Development
Table 95. Chinese Peptide Corporation Information
Table 96. Chinese Peptide Description and Business Overview
Table 97. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 98. Chinese Peptide Antimicrobial Peptides Product
Table 99. Chinese Peptide Recent Development
Table 100. Ontores Corporation Information
Table 101. Ontores Description and Business Overview
Table 102. Ontores Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 103. Ontores Antimicrobial Peptides Product
Table 104. Ontores Recent Development
Table 105. GenScript Corporation Information
Table 106. GenScript Description and Business Overview
Table 107. GenScript Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 108. GenScript Antimicrobial Peptides Product
Table 109. GenScript Recent Development
Table 110. Hycult Biotech Corporation Information
Table 111. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 112. Hycult Biotech Description and Business Overview
Table 113. Hycult Biotech Antimicrobial Peptides Product
Table 114. Hycult Biotech Recent Development
Table 115. Sunsmile Corporation Information
Table 116. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 117. Sunsmile Description and Business Overview
Table 118. Sunsmile Antimicrobial Peptides Product
Table 119. Sunsmile Recent Development
Table 120. Ruixing Biotechnology Corporation Information
Table 121. Ruixing Biotechnology Description and Business Overview
Table 122. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 123. Ruixing Biotechnology Antimicrobial Peptides Product
Table 124. Ruixing Biotechnology Recent Development
Table 125. Zhongnong Yingtai Biotechnology Corporation Information
Table 126. Zhongnong Yingtai Biotechnology Description and Business Overview
Table 127. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 128. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 129. Zhongnong Yingtai Biotechnology Recent Development
Table 130. Glam Technology Corporation Information
Table 131. Glam Technology Description and Business Overview
Table 132. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2015-2020)
Table 133. Glam Technology Antimicrobial Peptides Product
Table 134. Glam Technology Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Antimicrobial Peptides Distributors List
Table 138. Antimicrobial Peptides Customers List
Table 139. Antimicrobial Peptides Market Key Trends
Table 140. Antimicrobial Peptides Key Opportunities and Drivers
Table 141. Antimicrobial Peptides Market Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Antimicrobial Peptides Product Picture
Figure 2. Global Antimicrobial Peptides Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antimicrobial Peptides Market Share by Application in 2020 & 2026
Figure 6. Pharmaceuticals Examples
Figure 7. Feed Additives Examples
Figure 8. Others Examples
Figure 9. Global Antimicrobial Peptides Sales (Mg) Growth Rate (2015-2026)
Figure 10. Global Antimicrobial Peptides Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Antimicrobial Peptides Price Trends Growth Rate (2015-2026) (US$/Mg)
Figure 12. Global Antimicrobial Peptides Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Antimicrobial Peptides Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Antimicrobial Peptides Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Antimicrobial Peptides Sales (Mg) Growth Rate (2015-2026)
Figure 16. Europe Antimicrobial Peptides Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Antimicrobial Peptides Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Antimicrobial Peptides Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Antimicrobial Peptides Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Antimicrobial Peptides Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Antimicrobial Peptides Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Antimicrobial Peptides Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Antimicrobial Peptides Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Antimicrobial Peptides Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Antimicrobial Peptides Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Antimicrobial Peptides Players Market Share by Revenue in Antimicrobial Peptides 2015 & 2019
Figure 27. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Antimicrobial Peptides Revenue Share by Type (2015-2020)
Figure 29. Global Antimicrobial Peptides Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Antimicrobial Peptides Revenue Share by Application (2015-2020)
Figure 31. Global Antimicrobial Peptides Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Antimicrobial Peptides Sales Market Share by Type in 2019
Figure 33. United States Antimicrobial Peptides Sales Market Share by Type in 2019
Figure 34. Europe Antimicrobial Peptides Sales Market Share by Company in 2019
Figure 35. Europe Antimicrobial Peptides Sales Market Share by Type in 2019
Figure 36. Europe Antimicrobial Peptides Sales Market Share by Application in 2019
Figure 37. China Antimicrobial Peptides Sales Market Share by Company in 2019
Figure 38. China Antimicrobial Peptides Sales Market Share by Type in 2019
Figure 39. China Antimicrobial Peptides Sales Market Share by Application in 2019
Figure 40. Japan Antimicrobial Peptides Sales Market Share by Company in 2019
Figure 41. Japan Antimicrobial Peptides Sales Market Share by Type in 2019
Figure 42. Japan Antimicrobial Peptides Sales Market Share by Application in 2019
Figure 43. Southeast Asia Antimicrobial Peptides Sales Market Share by Company in 2019
Figure 44. Southeast Asia Antimicrobial Peptides Sales Market Share by Type in 2019
Figure 45. Southeast Asia Antimicrobial Peptides Sales Market Share by Application in 2019
Figure 46. India Antimicrobial Peptides Sales Market Share by Company in 2019
Figure 47. India Antimicrobial Peptides Sales Market Share by Type in 2019
Figure 48. India Antimicrobial Peptides Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Antimicrobial Peptides
Figure 51. Manufacturing Process Analysis of Antimicrobial Peptides
Figure 52. Antimicrobial Peptides Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed